Table 1.
Age-adjusted incidence rates of primary malignant spinal cord tumor patients by variables of interest diagnosed in 1973 to 2006.
Variable of Interest | No. (%) | Incidence ratex | 95% CIxx |
---|---|---|---|
OVERALL | 988 (100) | 0.12 | (0.12,0.13) |
Age at diagnosis | |||
0–9 | 91 (9.21) | 0.08 | (0.06, 0.09) |
10–19 | 110 (11.13) | 0.09 | (0.07,0.11) |
20–34 | 238 (24.09) | 0.12 | (0.11,0.14) |
35–49 | 278 (28.14) | 0.17 | (0.15,0.19) |
50–64 | 180 (18.22) | 0.16 | (0.13,0.18) |
65+ | 91 (9.21) | 0.10 | (0.08,0.12) |
Sex | |||
Male | 557 (56.38) | 0.14 | (0.13,0.16) |
Female | 431 (43.62) | 0.11 | (0.10,0.12) |
Race | |||
White | 850 (86.03) | 0.13 | (0.12,0.14) |
Black | 86 (8.70) | 0.09 | (0.07,0.12) |
Other* | 52 (5.26) | 0.07 | (0.06,0.10) |
Histological type | |||
Astrocytoma Grade I | 77 (7.79) | 0.009 | (0.007,0.01) |
Astrocytoma Grade II | 31 (3.14) | 0.004 | (0.003,0.005) |
Astrocytoma Grade II–III | 26 (2.63) | 0.003 | (0.002,0.005) |
Astrocytoma Grade III | 38 (3.85) | 0.005 | (0.003,0.007) |
GBM | 39 (3.95) | 0.005 | (0.003,0.007) |
Astrocytoma, NOS | 228 (23.08) | 0.03 | (0.02,0.03) |
Ependymoma | 549 (55.57) | 0.07 | (0.06,0.08) |
Primary Site | |||
C70.1-Spinal meninges | 6 (0.61) | 0.0008 | (0.0003,0.002) |
C72.0-Spinal cord | 964 (97.57) | 0.12 | (0.11,0.13) |
C72.1-Cauda equina | 18 (1.82) | 0.002 | (0.001,0.004) |
Incidence rates are per 100,000 and age-adjusted to the 2000 US Standard Population
95% Confidence interval for incidence rate.
American Indian/AK Native, Asian/Pacific Islander